USFDA places clinical hold on Phase 3 Tolebrutinib studies: Sanofi Ruchika Sharma2 July 2022 12:45 PM ISTThe FDA action was based on a limited number of cases of drug-induced liver injury that have been identified with tolebrutinib exposure in Phase 3...
GSK-Sanofi variant-specific COVID vaccine found effective against Omicron Ruchika Sharma24 Jun 2022 4:30 PM ISTParis: Sanofi and GSK today announced positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta (B.1.351) vaccine...
'Golden time for India to emerge as innovator nation in biopharma sector' Ruchika Sharma23 Jun 2022 3:30 PM ISTWashington: Post COVID19, it's a golden time for India to emerge as an innovator nation in the biopharma sector, organiser of the annual India-US...
Upgraded version of COVID booster shot has potential against main variants: Sanofi Ruchika Sharma13 Jun 2022 3:02 PM ISTParis: French drugmaker Sanofi said on Monday an upgraded version of the COVID-19 vaccine candidate it is developing with GSK showed potential in...
Sanofi Dupixent wins USFDA nod for atopic dermatitis Ruchika Sharma8 Jun 2022 1:00 PM ISTDupixent is administered as an injection under the skin (subcutaneous injection) at different injection sites.
Sanofi to transfer 100 percent rights of Libtayo to Regeneron Ruchika Sharma3 Jun 2022 12:34 PM ISTUpon closing of the transaction, Regeneron will make an upfront payment of $900 million to Sanofi, which will be entitled to receive an 11% royalty on...
Sanofi gets USFDA breakthrough therapy designation for hemophilia A drug Efanesoctocog alfa Ruchika Sharma2 Jun 2022 5:03 PM ISTHemophilia A occurs in about one in 5,000 male births annually, and more rarely in females.
Sanofi India names Preeti Futnani as new General Manager for vaccines Ruchika Sharma2 Jun 2022 11:57 AM ISTFutnani succeeds Annapurna Das, who is elevated to Head of Vaccines, Asia. Futnani will be based in Mumbai, India.
Sanofi Dupixent under USFDA priority review for adults with prurigo nodularis Ruchika Sharma31 May 2022 2:41 PM ISTDupixent is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways and is not...
Tadalafil switch from Rx to OTC: USFDA puts a clinical hold on Sanofi's Trial Ruchika Sharma30 May 2022 5:00 PM ISTParis: Sanofi has announced that U.S. Food and Drug Administration (USFDA) has placed clinical hold on its planned Actual Use Trial (AUT) to support...
Sanofi Dupixent gets USFDA nod for eosinophilic esophagitis Ruchika Sharma22 May 2022 10:00 AM ISTEoE is a chronic inflammatory disease driven by type 2 inflammation that damages the esophagus and prevents it from working properly.
Sanofi ordered to pay over Rs 3 crore as compensation for epilepsy drug-related side effects Ruchika Sharma17 May 2022 1:24 PM ISTThe court in Nanterre on Thursday ordered the company to compensate the parents of the girl for the various physical and psychological damages...
